ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer (BC) and is characterized by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and receptor 2 of the human epidermal growth factor (HER2).